Bicycle Therapeutics (BCYC) Retained Earnings (2018 - 2025)
Historic Retained Earnings for Bicycle Therapeutics (BCYC) over the last 8 years, with Q3 2025 value amounting to -$879.6 million.
- Bicycle Therapeutics' Retained Earnings fell 3985.5% to -$879.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$879.6 million, marking a year-over-year decrease of 3985.5%. This contributed to the annual value of -$680.8 million for FY2024, which is 3302.93% down from last year.
- Bicycle Therapeutics' Retained Earnings amounted to -$879.6 million in Q3 2025, which was down 3985.5% from -$820.5 million recorded in Q2 2025.
- In the past 5 years, Bicycle Therapeutics' Retained Earnings registered a high of -$167.8 million during Q1 2021, and its lowest value of -$879.6 million during Q3 2025.
- Moreover, its 5-year median value for Retained Earnings was -$412.8 million (2023), whereas its average is -$449.9 million.
- In the last 5 years, Bicycle Therapeutics' Retained Earnings plummeted by 5456.54% in 2023 and then plummeted by 3302.93% in 2024.
- Quarter analysis of 5 years shows Bicycle Therapeutics' Retained Earnings stood at -$218.4 million in 2021, then tumbled by 51.62% to -$331.1 million in 2022, then crashed by 54.57% to -$511.8 million in 2023, then tumbled by 33.03% to -$680.8 million in 2024, then decreased by 29.2% to -$879.6 million in 2025.
- Its Retained Earnings stands at -$879.6 million for Q3 2025, versus -$820.5 million for Q2 2025 and -$741.5 million for Q1 2025.